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Edited by Masayuki MiyasakaAbstract Klotho mutant mice exhibit a set of phenotypes
resembling human ageing. Although the function of Klotho
remains unclear, mediation of its pleiotropic functions by
putative humoral factor(s) has been presumed. Newly established
antibodies against Klotho allowed the detection of secreted
Klotho, a candidate for the putative humoral factor, in sera and
cerebrospinal ﬂuid. Surprisingly the secreted Klotho was 130
kDa, in contrast to the 70 kDa predicted form from klotho gene
transcripts. The secreted as well as the membrane-bound Klotho
proteins were suggested to form oligomerized complex. These
results delineate post-translation processing of Klotho and
possible regulatory mechanisms for secretion of Klotho in vivo.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Post-translational cleavage1. Introduction
klotho mutant mice were originally described as an animal
model harboring a set of phenotypes resembling human ageing
[1]. The klotho (kl) gene encodes a type I membrane protein
with an extracellular domain possessing two internal repeats
(KL1, KL2) that share homology to family 1 b-glycosidase [2].
In kl/kl mice, some of the major changes are thought to occur
in a cell-non-autonomous fashion, because klotho is predomi-
nantly expressed in the kidney, the parathyroid gland, and the
choroid plexus, but not detectable in many organs that are
severely aﬀected. In addition, transgenic expression of klotho,
though limited to brain and testis, improved macroscopic ab-
normalities observed in kl/kl mice [1]. The limited delivery of* Corresponding author. Fax: +81-75-753-4676.
E-mail address: nabemr@lmls.med.kyoto-u.ac.jp (Y.-I. Nabeshima).
Abbreviations: SDS–PAGE, sodium dodecyl sulfate-polyacrylamide
gel electrophoresis; CSF, cerebrospinal ﬂuid; HA, hemagglutinin; FBS,
fetal bovine serum; HRP, horseradish peroxydase; CHO, Chinese
hamster ovary; MEM, minimum essential medium; DTT, dithiothre-
itol; EDTA, ethylenediaminetetraacetic acid; RT, room temperature;
mAb, monoclonal antibody
0014-5793/$22.00  2004 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2004.03.090Klotho and the exchange of humoral elements by parabiosis
showed some protective eﬀects in vivo [3–5]. Taken together,
these ﬁndings suggested that functional deﬁciency of extra-
cellular factor(s) should be involved in the pathogenesis shown
in klotho mutant mice.
An alternatively spliced form of klothomRNA, encoding the
N-terminal half of Klotho (KL1), was detected in humans [6]
and mice [7] and led to the hypothesis that a secreted form of
Klotho existed extracellularly. It was also speculated that this
putative secreted KL1 protein might play a signiﬁcant role as a
humoral factor to protect organs from various impairments.
In the present study, we developed new monoclonal anti-
bodies (mAbs) against Klotho and succeeded in detecting a
130 kDa Klotho protein in both serum and cerebrospinal ﬂuid
(CSF). Secreted KL1 predicted from klotho gene transcripts
was not detected in extracellular ﬂuid. Here, we report the
molecular characterization of Klotho proteins.2. Materials and methods
2.1. Plasmid construction
The expression vectors for full-length mouse Klotho fused with
EGFP, hemagglutinin (HA) or Flag tag at the C-termini were con-
structed. In order to introduce a translational initiation sequence and
an EcoRI site to the 50 region of mouse klotho cDNA, the 50 end of
klotho cDNA, termed mKL-N, was ampliﬁed via PCR using a set of
primers; mKL-S1, 5-aaagaattcgccaccatgctagcccgcgcc-3 (EcoRI and
Kozak initiation sequences are underlined) and mKL-AS1, 5-cat-
ggctgaattctcccagtcag-3. To delete the stop codon and add a BamHI site
into the 30 region, a set of primers; mKL-S3, 5-aggaggatccgat-
gaaatacaacg-3 (BamHI site is underlined) and mKL-AS3, 5-
tttctcgagcttataacttctctggcctttcttgg-3 (XhoI site is underlined) were used
to amplify the 30 end of klotho cDNA, termed mKL-C. The EcoRI–
BamHI fragment of mKL-N and BamHI–XhoI fragments was ligated
and cloned into EcoRI–XhoI sites of pSP72 giving PSP72-klotho. Then,
the EcoRI–XhoI fragment of PSP72-klotho was excised and inserted
into pEGFP-N2 (Clontech), pcDNA3-HAC and pcDNA3-FlagC
(Invitrogen) to give KL-EGFPC, KL-HAC and KL-FlagC, respec-
tively.
2.2. Animals
klotho null mice are described elsewhere [8]. C57BL/6 mice and
Sprague–Dawley rats were purchased from CLEA Inc. Japan. All the
animals were maintained in SPF conditions according to the institute’s
guidelines.blished by Elsevier B.V. All rights reserved.
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Chinese hamster ovary (CHO) cells were cultured in minimum es-
sential (MEM) alpha medium (Sigma) containing 1% (v/v) fetal bovine
serum (FBS), 100 U/ml of penicillin, 0.0001% (w/v) streptomycin and 2
mM L-glutamine (Sigma). Four micrograms of plasmid was intro-
duced into 107 cells using LipofectAMINE PLUS reagent (Invitrogen)
and geneticine (Invitrogen) resistant colonies were selected. CHOTM2,
a high producer of full-length Klotho, was a gift of KYOWA Hakko
Kogyo, Co. Ltd. Mouse kidneys and choroid plexus were dissected,
suspended in phosphate-buﬀered saline (PBS), and cultured in RE-
BMTM medium (Clonetics) for 24 h at 37 C in a CO2 incubator.
Choroid plexus were treated with 0.5 mg/ml of EZ-LinkTM Sulfo-
NHS-LC-Biotin (Pierce) for 30 min on ice to biotinylate cell surface
proteins, rinsed twice with cold PBS and then cultured.
2.4. Monoclonal antibodies
All mAbs were developed as described elsewhere [9]. Hybridoma
supernatants were screened based on histological staining aﬃnities for
klotho-transfected CHO cells and abilities for immunoprecipitation
(IP) of recombinant Klotho proteins. 131 mAb is a mouse IgG1 an-
tibody against human OX40 [9] and used as a subclass matched con-
trol. Puriﬁed mAbs were conjugated to hydrazide beads (Bio-Rad)
according to the manufacturer’s instructions. For IPs of HA-tagged
and Flag-tagged Klotho proteins, anti-HA agarose conjugated beads
(Sigma) and anti-FLAG M2 aﬃnity gel (Sigma) were purchased, re-
spectively.
2.5. Western blot analysis
Kidneys were homogenized and lysed in lysis buﬀer containing 20
mM HEPES, pH 7.4, 150 mM NaCl, CompleteTM (Roche) and 2%
CHAPS and incubated at 4 C overnight. Ten micrograms of super-
natant proteins (14 000 rpm for 30 min) measured by DC protein assay
kit (Bio-Rad) was analyzed by sodium dodecyl sulfate–polyacrylamide
gel electrophoresis (SDS–PAGE) and electrically transferred onto
PVDF membranes (Immobilon; Millipore). The blot was incubated
with 1 lg/ml of monoclonal anti-Klotho antibodies for 60 min and
then incubated with horseradish peroxidase (HRP)-conjugated goat
anti-rat Ig (1:5000, Bio Source) for 30 min. Bands were visualized using
the ECL plus system (Amersham Biosciences). Choroid plexus were
treated with the above lysis buﬀer containing 4% CHAPS overnight to
extract soluble proteins. About 2 lg proteins from the supernatants
were analyzed by Western blotting.
2.6. Immunoprecipitation from serum or CSF
Blood samples were obtained from human volunteers and mice. Two
human CSF samples from therapeutic drainage performed at Kyoto
University Hospital were utilized for this experiment according to the
institute’s guidelines. Serum and CSF were diluted with an equal
volume of buﬀer containing 20 mM Tris–HCl, pH 7.5, 150 mM NaCl,
0.5% Triton X-100 and 2 mM ethylenediaminetetraacetic acid (EDTA)
and ﬁltered with 0.45 lm millex ﬁlter (Millipore). One milliliter of
diluted serum and CSF samples were incubated with 20 ll of beads
conjugated with Mink1 (mouse antibody) or 131 mAb, a control an-
tibody at 4 C for 3 h. Incubated beads were washed ﬁve times with a
buﬀer containing 20 mM Tris–HCl, pH 7.5, 200 mM NaCl, 0.5%
Triton X-100 and 2 mM EDTA. Immunoprecipitated proteins were
eluted by incubation at 95 C for 5 min in 20 ll of 2· sample buﬀer
(60% (v/v) glycerol, 4% SDS, 10 mM EDTA and 125 mM Tris, pH 6.8)Table 1
Characterization of mAbs
MAb Animal Subclass Antigen
KM2076 Rat IgG2a N-KL-GST
KM2119 Rat IgG2b C-KL-GST
Mink1 Mouse IgG1 rKL
Rink6 Rat IgG2b rKL
Rink12 Rat IgG2a rKL
Rink14 Rat IgG2b rKL
Rink107 Rat IgG2a rKL
aKM2076 and KM2119 give a single band with 120 kDa in IP method. +,
eﬃciency of IP. N- or C-KL-GST: N-terminal or C-terminal recombinant Kl
rKL: recombinant mouse Klotho protein from CHO supernatants.without a reducing reagent and 10 mM dithiothreitol (DTT) was ad-
ded after removal from the beads.
2.7. Immunoprecipitation from transfectants
Cos-7 cells transiently transfected with expression vectors for KL-
HAC, KL-FlagC, or both were washed twice with cold PBS and lysed
in ice-cold cell lysis buﬀer (20 mM HEPES, pH 7.4, 1% Triton X-100
and 150 mM NaCl containing a CompleteTM). Supernatants of lysates
at 14 000 rpm for 30 min were incubated with Sepharose 4B (Amer-
sham Bioscience) for 1 h to remove non-speciﬁcally bound materials.
For IPs, 10 ll of agarose beads conjugated with monoclonal anti-HA
antibody (Sigma) or anti-FLAGM2 aﬃnity gel (Sigma) was incubated
with 100 ll of pre-cleared lysate for 16 h. The precipitants were then
washed with buﬀer containing 20 mM HEPES, pH 7.4, 150 mM NaCl
and 0.5% Triton X-100. Proteins were eluted after incubation with 2·
sample buﬀer at 95 C, applied to SDS–PAGE and then transferred to
Immobilon-P (Millipore). The immunoblots were probed with the
anti-HA or anti-Flag M2 antibody and then developed with HRP-
conjugated donkey anti-mouse IgG (Amersham Bioscience) or HRP-
conjugated sheep anti-mouse IgG (Amersham Bioscience) and exposed
to hyperﬁlmTM (Amersham Bioscience) using chemiluminescence ECL
plus reagent.
2.8. Size exclusive chromatography
Twenty milliliters of culture supernatant of CHOTM2 was passed
through 0.22 lm ﬁlter and concentrated to 0.5 ml with size exclusive
spin columns (Vivascience). The samples (50 ll) were applied to a
TSK-3000SWXL column (TOSOH, Japan) equilibrated with 100 mM
sodium phosphate buﬀer (pH 6.8) containing 200 mM NaCl and 2
mM EDTA using a liquid chromatography system (BioCAD 700E,
Applied Biosystems) at a ﬂow rate of 0.5 ml/min at room tempera-
ture (RT). Fractions (100 ll) were collected and analyzed by Western
blot with KM2076 using a chemiluminescence imaging analyzer
(LAS3000mini, FUJI Film, Japan). The molecular weights of eluted
Klotho proteins were estimated with molecular weight standards
(Gel Filtration Standard, Bio-Rad) monitored by UV absorbance at
280 nm.3. Results
3.1. Establishment of mAbs
We established a series of mAbs recognizing Klotho
proteins in order to analyze whether Klotho exists in ex-
tracellular ﬂuid. Newly established (Rink6, Rink12, Rink14,
Rink107 and Mink1) and previously established (KM2076
and KM2119) mAbs [10] were characterized (Table 1).
KM2076 and KM2119 are both useful for Western blot
analysis to detect 120, 130 and 135 kDa Klotho proteins.
On the contrary, IP of lysates from mouse kidney and
choroid plexus with KM2076 and KM2119 gave a single
band of 120 kDa. Newly established mAbs were all useful
for immunohistochemistry (IHC) and IP of Klotho proteins,
but not for Western blotting.Recognition site Western blot IHC IP
KL1 Yes + +a
KL2 Yes + +a
KL1 No ++ +++
KL1 No ++ +++
KL1 No +++ +++
KL1 No +++ ++
KL1 No ++ +++
++ and +++ represent intensities of ﬂuorescence signals for IHC and
otho proteins fused with GST protein from E. coli lysates, respectively.
Fig. 1. Characterization of secreted Klotho. (a) Lysates of kidneys
from female C57BL/6 (W) and kl)/) mice were subjected to Western
blotting with KM2076 following SDS–PAGE with 7.5–15% gradient
polyacrylamide gel. (b) Klotho protein in mouse sera was immuno-
precipitated using Mink1-conjugated beads and (c) human sera and
CSF were used for immunoprecipitation with Mink1 (M1) or with
control antibody (C), and subjected to Western blot analysis with
KM2076. (d, e) Klotho in lysates (L) and organ culture supernatants
(S) of kidneys and choroid plexus (CP) from C57BL/6 mice were im-
munodetected with KM2076 as described in (a). In both lysates, two
bands corresponding 120 and 135 kDa were detected (arrowheads).
(f, g) Choroid plexus were labeled with biotin for 30 min in PBS on ice.
Cell lysate (L) was prepared just after labeling. In addition, labeled
choroid plexus were cultured for 3 h and the conditioned media were
used for immunoprecipitation with Mink1 anti-Klotho antibody (S).
These samples were immunoblotted with either HRP-conjugated
streptavidin (f) or KM2076 mAb (g). (h, i) Mouse klotho and klotho-
EGFP expression plasmids were transfected into CHO cells, respec-
tively, and the lysates and the supernatants were immunodetected with
either KM2076 mAb (h) or anti-GFP antisera (i).
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To characterize Klotho proteins, lysates of kidneys and im-
munoprecipitants of sera from C57BL/6 and kl)/) mice were
examined by Western blot analysis using KM2076 mAb. Dis-
tinct bands were seen in the kidney lysate (120 and 135 kDa) and
immunoprecipitants (130 kDa) from sera of C57BL/6 mice but
not in those from kl)/) mice (Fig. 1(a) and (b)). The same
method was applied for the analysis of human sera and CSF. A
unique band of 130 kDa was detected in the IP with Mink1-
conjugated beads, but not with negative control beads
(Fig. 1(c)), demonstrating that a soluble Klotho protein of 130
kDa exists in extracellular ﬂuids in humans and mice.3.3. Release of Klotho protein by proteolysis
To assess the possibility of release of membrane-bound
Klotho protein, we examined lysates and supernatants using
mouse kidney and choroid plexus. In both organs, dual
bands of 120 and 135 kDa were detected from lysates, while
a single band of 130 kDa was seen in supernatants (Fig. 1(d)
and (e)). To further characterize the secretion of Klotho
protein, cell surface molecules on mouse choroid plexus cells
were labeled with water soluble-biotin, immunoprecipitated
with Mink1-conjugated beads, and applied to Western blot
analysis. The upper 135 kDa band was obviously biotiny-
lated. On the contrary, the lower band (120 kDa) was not
detected with streptavidin (Fig. 1(f)), but detectable when
the same membrane was visualized with KM2076 (Fig. 1(g)).
These results suggest that the biotinylated upper band rep-
resents the cell surface form of Klotho and the lower 120
kDa band should be the intracellular form of Klotho. 130
kDa of Klotho protein (Fig. 1(f)), detected in the superna-
tant, was also labeled with biotin, suggesting that this se-
creted Klotho, at least in part, was once present on the cell
surface membrane and then secreted from the cell surface to
supernatant, because tissues were biotinylated shortly, wa-
shed out thoroughly and then cultured. We next introduced
klotho and klotho-EGFP expression plasmids into CHO
cells, respectively. Distinct dual bands, corresponding to the
products of the transfected cDNAs, were observed in the cell
lysates, whereas the both supernatants commonly gave a 130
kDa band (Fig. 1(h)). Additionally, in immunodetection
with anti-GFP antisera, the EGFP domain that fused with
C-terminus of Klotho was not detectable in the supernatant
of Klotho-EGFP expressing cells (Fig. 1(i)), suggesting that
the 130 kDa Klotho detected in serum and CSF should be
cleaved from cell membrane.3.4. Glycosylation of Klotho protein alters its relative mobility
As shown in Fig. 2(a), Mink1 mAb precipitated two bands
of 135 and 120 kDa from the lysate of CHOTM2 and a single
band of 130 kDa from the culture media of the same cells,
while KM2119 mAb precipitated only 120 kDa band from the
cell lysate. Treated with N-glycosidase, both immunoprecipit-
ants from cell lysate revealed a unique band of about 110 kDa
that is consistent with the predicted molecular weight from
amino acid residues, whereas the product of secreted Klotho
protein treated with N-glycosidase gave a single band with a
little accelerated mobility than those of membrane-bound
Klotho proteins. This phenomenon was also conﬁrmed by the
addition of tunicamycin, an inhibitor of N-glycosylation, to
the culture (Fig. 2(b)). These data suggested that the diﬀerence
Fig. 3. Oligomerized formation of Klotho. The concentrated super-
natant of CHOTM2 was separated through a size exclusive gel ﬁltra-
tion system. Absorbance of UV (280 nm) was monitored and blotted
as a solid line. The positions of three marker proteins used for mo-
lecular weight standards are indicated. Collected fraction samples were
subjected to immunoblotting and the amounts of Klotho protein were
measured and blotted as a dotted line (a). Cos-7 cells were transfected
with expression vectors for HA-tagged (pcDNA3-Klotho-HA) and/or
Flag-tagged (pcDNA3-Klotho-Flag) Klotho. After a 48 h incubation,
cell lysates (lanes 1–6) and immunoprecipitants with M2, an anti-Flag
antibody (lanes 7–9) and an anti-HA antibody (lanes 10–12) were
analyzed by Western blotting (b).
Fig. 2. Post-translational modiﬁcation of Klotho by N-glycosylation.
(a) Klotho was immunoprecipitated with Mink1 or KM2119-conju-
gated beads from lysates or culture media of CHOTM2. The products
were then treated with (+) or without ()) N-glycosidase for 30 min at
37 C, and applied for immunoblotting with KM2076. (b) CHOTM2
cells were treated with (+) or without ())1 lg/ml tunicamycin for 90
min at 37 C, and lysed for immunoblot analysis with KM2076.
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the diﬀerent attached sugar moieties and the secreted Klotho
protein was glycosylated as well as membrane-bound Klotho.
3.5. Oligomerized formation of Klotho
Since b-glycosidase family members have been suggested to
have a tendency to dimerize, we examined the association of
Klotho proteins by size exclusive gel ﬁltration. Secreted Klotho
protein was estimated to be between 158 and 670 kDa by com-
parison with molecular weight markers, suggesting that Klotho
was oligomerized or bound to the other protein(s) (Fig. 3(a)). To
examine the possibility of self-association of klotho protein,
Cos-7 cells expressing Klotho-HA, Klotho-Flag or both were
lysed and coimmunoprecipitated with either anti-HA or anti-
Flag antibody-conjugated beads. As a result, anti-Flag anti-
body-conjugated beads could immunoprecipitate HA-tagged
Klotho and conversely, anti-HA antibody-conjugated beads
also could immunoprecipitate Flag-tagged Klotho (Fig. 3(b)).
These data support the hypothesis that Klotho protein should
self-associate at least in the cells and be oligomerized as a unique
molecular complex in the extracellular ﬂuids.4. Discussion
Despite our attempts, we could not detect soluble KL1, the
product of alternatively spliced klotho mRNA in extracellular
compartments. mRNA encoding soluble KL1 is very low in
mice but apparently considerable in humans [6,7]. Thus, at
least in humans, detectable amounts of KL1 may possibly be
produced and secreted, but then might be rapidly eliminated to
undetectable levels in serum. On the contrary, 130 kDa Klothoproteins are found in both sera and CSF. Previous failure in
detection of the secreted Klotho may be due to the potency of
the original antibodies used, because KM2076 and KM2119
react preferentially to 120 kDa Klotho, suggested as a intra-
cellular form, in IP method (Table 1).
Previous studies suggested that humoral factor(s) might me-
diate the biological function of Klotho, at least in part and its
deﬁciencymight be involved in theunique state of klothomutant
mice [1,3–5]. In these examinations, the full-length klotho cDNA
was always utilized and shown to be eﬀective for the rescue of
mutant phenotypes, whereas the ectopic expression of the
spliced variant klotho cDNA encoding only KL1 was not
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lating evidences suggest a possible importance of the products of
full-length klotho cDNA and it is possible to propose a revised
hypothesis that the secreted 130 kDa Klotho may play an im-
portant role in vivo.For the functional evaluationof the secreted
Klotho, it is critical to distinguish the humoral action of the
secreted Klotho itself from the humoral events resulting from
the cell-autonomous function of membrane-bound Klotho.
Nonetheless, the type of events that can induce the release of
Klotho, the extent of its range, or where it accumulates in vivo,
have yet to be addressed. The determination of the exact
cleavage site and the identiﬁcation of the cleavage enzyme
remain to be solved. It is also necessary to study the role(s) of
the secreted Klotho in circulating CSF. This is in addition to
the evidence gathered for the cell autonomous actions of the
membrane Klotho. Future studies thus remain to resolve the
distinct physiological roles to which the secreted and mem-
brane forms of Klotho proteins contribute in vivo.
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